GD2 synthase
- 15 August 2001
- Vol. 92 (4) , 924-931
- https://doi.org/10.1002/1097-0142(20010815)92:4<924::aid-cncr1402>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Circulating Neuroblastoma Cells Detected by Reverse Transcriptase Polymerase Chain Reaction for Tyrosine Hydroxylase mRNA Are an Independent Poor Prognostic Indicator in Stage 4 Neuroblastoma in Children Over 1 YearJournal of Clinical Oncology, 2001
- Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group StudyJournal of Clinical Oncology, 2000
- Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastomaBritish Journal of Cancer, 1997
- MAGE-1 andMAGE-3 or-6 expression in neuroblastoma-related pediatric solid tumorsInternational Journal of Cancer, 1996
- Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastomaInternational Journal of Cancer, 1996
- Detection of Minimal Disease in Patients with Solid TumorsJournal of Hematotherapy, 1996
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytesImmunity, 1995
- Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601European Journal of Immunology, 1994
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991